Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults
Clinical trial NCT04617483 · COMPLETED
Trial details
- NCT number
- NCT04617483
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-31
- Primary completion
- 2020-11-28
- Enrollment
- 1040
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.